# Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients

> **NCT01612299** · NA · WITHDRAWN · sponsor: **University of Kentucky**

## Conditions studied

- Renal Transplant

## Interventions

- **DRUG:** Zortress® /Everolimus

## Key facts

- **NCT ID:** NCT01612299
- **Lead sponsor:** University of Kentucky
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-05
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding was withdrawn for this study by the sponsor.
- **Last updated:** 2017-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01612299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01612299, "Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01612299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*